NCT03285568
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
Not specified
Clinical trial condition
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Explore clinical trials studying Human Epidermal Growth Factor 2 Negative Carcinoma of Breast. Study availability and eligibility vary by location and protocol.
20 public trials
4 recruiting studies
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast trial results
Completed
Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer
NCT01934478
- Conditions
- Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Neoplasms
- Locations
-
- Qingdao Central Hospital, Qingdao Cancer Hospital Qingdao, Shandong, China
NCT02894398
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Research Site Aachen, Germany
- Research Site Aschaffenburg, Germany
- Augsburg, Germany
- Research Site Baden-Baden, Germany
NCT02871791
- Conditions
- Hormone Receptor (HR)-Positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01935492
- Conditions
- Breast Diseases, Breast Neoplasms, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, +5 more
- Locations
-
- BOOG Study Center Amsterdam, Netherlands
Completed
ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism
NCT02806817
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain
- H. Arnau de Vilanova Lleida Lleida, Spain
- Hospital Ramón y Cajal Madrid, Spain
- Hospital Universitario 12 de Octubre Madrid, Spain
NCT01548677
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Onze Lieve Vrouw Ziekenhuis Aalst, Belgium
- Hopital Universitaire Brugmann Brussels, Belgium
- Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme Brussels, Belgium
- Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
Completed
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
NCT01288261
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +9 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
NCT01885013
- Conditions
- Breast Diseases, Breast Neoplasms, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, +4 more
- Locations
-
- P.O. M. Bufalini Cesena, FC, Italy
- UO Oncologia Medica IRCCS IRST Meldola (FC), FC, Italy
- Ospedale Civile degli Infermi Faenza, RA, Italy
- Ospedale Umberto I Lugo, RA, Italy
Active, Not Recruiting
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
NCT02623972
- Conditions
- Breast Diseases, Breast Neoplasms, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, +6 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States